MyCEI Login


Mpox Now: Update on Prevention, Diagnosis & Treatment for People With or At-risk for HIV


Published Date: 06/17/2024

Expiration Date: 05/20/2027

CE Credit: CME:1


Mpox is not in the news as much this year as it was when it first exploded into our awareness in 2022. But mpox is still a concern as we approach the summer months, with its constant circulation in NYC and a large outbreak overseas that poses risk for a larger resurgence in the U.S. Mpox continues to mostly affect our patients with and at-risk for HIV, especially MSM. Understanding its epidemiology and vaccinating people at risk is critical in mitigating the ongoing effects of this STI. Don’t miss this important update on mpox from Dr. Preeti Pathela from the New York City Department of Health & Mental Hygiene.


Preeti Pathela,DrPH, MPH

Preeti Pathela is the Executive Director of the STI Program in the Bureau of Hepatitis, HIV, and STI at the New York City Department of Health and Mental Hygiene, with overall responsibility for directing, evaluating, and coordinating the activities of the Program, which consists of roughly 70 staff who conduct work in STI program implementation, surveillance and field operations, and epidemiology, research and evaluation. She has 18 years of experience in STI/HIV prevention and control, with a previous role of Director of STI Research and Evaluation at the NYC Health Department, during which time she oversaw a unit comprising analysts who examined data on STI/HIV patterns among the program’s sexual health clinic population, as well as at the citywide level, to generate and answer research questions around STD/HIV risk, prevention, and service delivery. She serves on the American STD Association’s Board of Directors and as an Associate Editor of Sexually Transmitted Diseases. Preeti received a DrPH degree in Epidemiology from the Johns Hopkins Bloomberg School of Public Health and her MPH from Emory University.

Learning Objectives

  • Understand ongoing community transmission of mpox in NYC and optimal methods for prevention, diagnosis, and treatment.
  • Know details of the outbreak of Clade I mpox virus in the Democratic Republic of the Congo and risk for its introduction into the U.S.
  • Be aware of changes to availability and ordering of JYNNEOS vaccine.
  • Know how to access available provider resources regarding mpox.

Continuing Education Credit Information